Overview of the Canadian pediatric end-stage renal disease database

Susan M Samuel1, Marcello A Tonelli, Bethany J Foster

  • 1Division of Pediatric Nephrology, Department of Pediatrics, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary T3B 6A8, Canada. s.samuel@albertahealthservices.ca

BMC Nephrology
|August 28, 2010
PubMed

Insights

Linking organ failure registry data with health administrative data creates a powerful Canadian Pediatric End-Stage Renal Disease database. This resource enables longitudinal studies on pediatric end-stage renal disease outcomes, including death, graft loss, and cardiovascular events.

Area of Science:

  • Pediatric Nephrology
  • Clinical Research Methodology
  • Health Informatics

Background:

  • Clinical research in pediatric end-stage renal disease (ESRD) faces challenges due to small sample sizes and limited longitudinal data.
  • Single-center studies often lack the statistical power and comprehensive follow-up needed for robust clinical outcomes research in pediatric ESRD.
  • Existing barriers hinder the successful initiation and completion of critical research projects for this vulnerable population.

Purpose of the Study:

  • To describe the construction and utility of a linked database for pediatric end-stage renal disease (ESRD) research in Canada.
  • To demonstrate how integrated registry and administrative health data can overcome limitations in studying pediatric ESRD outcomes.
  • To establish a foundation for longitudinal investigations into risk factors affecting pediatric ESRD patients.

Main Methods:

  • Longitudinal organ failure disease registry data were linked with administrative health datasets within Canada's universal healthcare system.
  • Deterministic linkage techniques were employed to create the Canadian Pediatric End-Stage Renal Disease database.
  • The database incorporates socio-demographic, clinical variables, hospitalizations, and validated definitions for cardiovascular events, death, and renal allograft loss.

Main Results:

  • The linked database provides a comprehensive resource for studying pediatric end-stage renal disease (ESRD) patients.
  • It enables the analysis of hard clinical endpoints, including death, renal allograft loss, and major cardiovascular events.
  • The integrated data facilitates the examination of both medical and non-medical risk factors impacting patient outcomes.

Conclusions:

  • Linking organ failure registries with health administrative data is a potent strategy for longitudinal research in pediatric ESRD.
  • The Canadian Pediatric End-Stage Renal Disease database offers rich clinical and demographic information for in-depth analysis.
  • This approach significantly enhances the capacity to study critical outcomes and risk factors in pediatric ESRD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...